New study tracks hidden sugar damage in patients on IV nutrition
NCT ID NCT07392801
First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This observational study will follow 50 adults and children who are starting long-term parenteral nutrition (IV nutrition) to measure the buildup of advanced glycation end-products (AGEs) in their skin. AGEs are harmful compounds that form when sugar binds with proteins, and they may increase with IV nutrition. Researchers will use a non-invasive skin device to track AGE levels over 12 months, along with diet and metabolic tests, to understand risk factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GLYCATION AND PRODUCTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HP - Hopital Robert Debré
NOT_YET_RECRUITINGParis, 75935, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Bordeaux - Hôpital Haut Lévêque
RECRUITINGPessac, 33600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Bordeaux-Hôpital des enfants GH Pellegrin
NOT_YET_RECRUITINGBordeaux, 33076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.